Gofen & Glossberg LLC Renalytix PLC Call Options Transaction History
Gofen & Glossberg LLC
- $3.89 Billion
- Q4 2022
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding RNLX
# of Institutions
31Shares Held
3.78MCall Options Held
0Put Options Held
0-
Pinnacle Associates LTD847KShares$126,9800.0% of portfolio
-
Stifel Financial Corp St. Louis, MO561KShares$84,1500.0% of portfolio
-
Levin Capital Strategies, L.P. New York, NY555KShares$83,2500.01% of portfolio
-
Tejara Capital LTD London, X0500KShares$75,0590.04% of portfolio
-
Ci Private Wealth, LLC Miami, FL336KShares$50,3270.0% of portfolio
About Renalytix plc
- Ticker RNLX
- Exchange OTC
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 37,445,900
- Market Cap $5.62M
- Description
- Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...